Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody

Bibliographic Details
Main Author: Pontes, Larissa Queiroz
Publication Date: 2019
Other Authors: Bezerra, Marcus Rafael Lobo, Fonseca, Marcela Helena Gambim, Lourenzoni, Marcos Roberto, Furtado, Gilvan Pessoa
Format: Conference object
Language: eng
Source: Repositório Institucional da FIOCRUZ (ARCA)
DOI: 10.35259/isi.sact.2019_32703
Download full: https://arca.fiocruz.br/handle/icict/32703
Summary: Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
id CRUZ_79c9bc7ba25e66a65e0866cde8367d9c
oai_identifier_str oai:arca.fiocruz.br:icict/32703
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Pontes, Larissa QueirozBezerra, Marcus Rafael LoboFonseca, Marcela Helena GambimLourenzoni, Marcos RobertoFurtado, Gilvan Pessoa2019-04-24T13:26:24Z2019-04-24T13:26:24Z2019PONTES, L. Q. et al. Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p. 99.https://arca.fiocruz.br/handle/icict/3270310.35259/isi.sact.2019_32703Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Universidade Federal do Ceará. Fortaleza, CE, Brasil.Universidade Federal do Ceará. Fortaleza, CE, Brasil.Fundação Oswaldo Cruz. Fiocruz Ceará. Fortaleza, CE, Brasil.Fundação Oswaldo Cruz. Fiocruz Ceará. Fortaleza, CE, Brasil.Fundação Oswaldo Cruz. Fiocruz Ceará. Fortaleza, CE, Brasil.engFiocruz/Instituto de Tecnologia em ImunobiológicosEngenharia de AnticorposMutagênese Sítio-DirigidaRituximabAntibody engineeringSite-directed mutagenesisRituximabMutagênese Sítio-DirigidaRituximabConstruction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibodyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://arca.fiocruz.br/bitstreams/e6bd2c9a-0750-4a92-9169-d66f4079ad4d/download8a4605be74aa9ea9d79846c1fba20a33MD51falseAnonymousREADORIGINALBIO_14.pdfapplication/pdf64380https://arca.fiocruz.br/bitstreams/75212fe0-b2e0-4405-8bd9-7c57bbb03109/downloaddcfa93c6c24d55715a6c947691388677MD52trueAnonymousREADTEXTBIO_14.pdf.txtBIO_14.pdf.txtExtracted texttext/plain3322https://arca.fiocruz.br/bitstreams/d04bf1f4-f986-436f-b8c7-2e2432ceebd8/downloade94e8de6bf7c3c8f32e6b5cf0306df6bMD55falseAnonymousREADTHUMBNAILBIO_14.pdf.jpgBIO_14.pdf.jpgGenerated Thumbnailimage/jpeg5000https://arca.fiocruz.br/bitstreams/ef9fbf99-3a2b-407b-b713-3af338111b1c/downloadf1d9c18af4af038a9a9daccb7565a121MD56falseAnonymousREADicict/327032025-07-29 22:24:46.573open.accessoai:arca.fiocruz.br:icict/32703https://arca.fiocruz.brRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352025-07-30T01:24:46Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)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
dc.title.none.fl_str_mv Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
title Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
spellingShingle Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
Pontes, Larissa Queiroz
Engenharia de Anticorpos
Mutagênese Sítio-Dirigida
Rituximab
Antibody engineering
Site-directed mutagenesis
Rituximab
Mutagênese Sítio-Dirigida
Rituximab
title_short Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
title_full Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
title_fullStr Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
title_full_unstemmed Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
title_sort Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
author Pontes, Larissa Queiroz
author_facet Pontes, Larissa Queiroz
Bezerra, Marcus Rafael Lobo
Fonseca, Marcela Helena Gambim
Lourenzoni, Marcos Roberto
Furtado, Gilvan Pessoa
author_role author
author2 Bezerra, Marcus Rafael Lobo
Fonseca, Marcela Helena Gambim
Lourenzoni, Marcos Roberto
Furtado, Gilvan Pessoa
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Pontes, Larissa Queiroz
Bezerra, Marcus Rafael Lobo
Fonseca, Marcela Helena Gambim
Lourenzoni, Marcos Roberto
Furtado, Gilvan Pessoa
dc.subject.other.none.fl_str_mv Engenharia de Anticorpos
Mutagênese Sítio-Dirigida
Rituximab
topic Engenharia de Anticorpos
Mutagênese Sítio-Dirigida
Rituximab
Antibody engineering
Site-directed mutagenesis
Rituximab
Mutagênese Sítio-Dirigida
Rituximab
dc.subject.en.none.fl_str_mv Antibody engineering
Site-directed mutagenesis
Rituximab
dc.subject.decs.none.fl_str_mv Mutagênese Sítio-Dirigida
Rituximab
description Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
publishDate 2019
dc.date.accessioned.fl_str_mv 2019-04-24T13:26:24Z
dc.date.available.fl_str_mv 2019-04-24T13:26:24Z
dc.date.issued.fl_str_mv 2019
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv PONTES, L. Q. et al. Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p. 99.
dc.identifier.uri.fl_str_mv https://arca.fiocruz.br/handle/icict/32703
dc.identifier.doi.none.fl_str_mv 10.35259/isi.sact.2019_32703
identifier_str_mv PONTES, L. Q. et al. Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p. 99.
10.35259/isi.sact.2019_32703
url https://arca.fiocruz.br/handle/icict/32703
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://arca.fiocruz.br/bitstreams/e6bd2c9a-0750-4a92-9169-d66f4079ad4d/download
https://arca.fiocruz.br/bitstreams/75212fe0-b2e0-4405-8bd9-7c57bbb03109/download
https://arca.fiocruz.br/bitstreams/d04bf1f4-f986-436f-b8c7-2e2432ceebd8/download
https://arca.fiocruz.br/bitstreams/ef9fbf99-3a2b-407b-b713-3af338111b1c/download
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
dcfa93c6c24d55715a6c947691388677
e94e8de6bf7c3c8f32e6b5cf0306df6b
f1d9c18af4af038a9a9daccb7565a121
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1839716122860978176

Similar Items